Upfront immune checkpoint inhibitors and long-term risk of major adverse cardiovascular events: a population-based propensity-matched cohort study

28 August 2026 (14:03 - 14:22)
Organised by: Logo
Congress Presentation Part of: Real-world evidence in cardio-oncology: what is it and what can it tell us? Cardio-Oncology ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology